# Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01116063** · PHASE4 · UNKNOWN · sponsor: **Carmel Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Inhaled iloprost

## Key facts

- **NCT ID:** NCT01116063
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2010-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116063, "Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01116063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*